Page last updated: 2024-10-25

cimetidine and Pulmonary Fibrosis

cimetidine has been researched along with Pulmonary Fibrosis in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Höltmann, BJ1
Schött, D1
Ulmer, WT1

Other Studies

1 other study available for cimetidine and Pulmonary Fibrosis

ArticleYear
[Diffuse interstitial lung disease following the use of cimetidine in a patient with severe reflux disease of the esophagus].
    Medizinische Klinik (Munich, Germany : 1983), 1989, Aug-15, Volume: 84, Issue:8

    Topics: Cimetidine; Gastroesophageal Reflux; Humans; Male; Middle Aged; Pulmonary Fibrosis

1989